These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 32410676)
1. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico. Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676 [TBL] [Abstract][Full Text] [Related]
2. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon. Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546 [TBL] [Abstract][Full Text] [Related]
3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. Ewen M; Zweekhorst M; Regeer B; Laing R PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413 [TBL] [Abstract][Full Text] [Related]
4. Availability, prices and affordability of selected essential medicines in Jordan: a national survey. Alefan Q; Amairi R; Tawalbeh S BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology. Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276 [TBL] [Abstract][Full Text] [Related]
6. Prices, availability and affordability of medicines in Rwanda. Bizimana T; Kayumba PC; Heide L PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100 [TBL] [Abstract][Full Text] [Related]
7. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria. Orubu ESF; Robert FO; Samuel M; Megbule D Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074 [TBL] [Abstract][Full Text] [Related]
8. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China. Zhu Y; Wang Y; Sun X; Li X Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326 [TBL] [Abstract][Full Text] [Related]
9. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889 [TBL] [Abstract][Full Text] [Related]
10. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348 [TBL] [Abstract][Full Text] [Related]
11. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Yang H; Dib HH; Zhu M; Qi G; Zhang X Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093 [TBL] [Abstract][Full Text] [Related]
12. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana. Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117 [TBL] [Abstract][Full Text] [Related]
13. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all. Kotwani A BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985 [TBL] [Abstract][Full Text] [Related]
14. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India. Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441 [TBL] [Abstract][Full Text] [Related]
15. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557 [TBL] [Abstract][Full Text] [Related]
16. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria. Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria. Osuafor NG; Ukwe CV; Okonta M PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799 [TBL] [Abstract][Full Text] [Related]
18. Are essential medicines in Malaysia accessible, affordable and available? Saleh K; Ibrahim MI Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951 [TBL] [Abstract][Full Text] [Related]
19. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937 [TBL] [Abstract][Full Text] [Related]
20. Availability, prices and affordability of essential medicines in Zhejiang Province, China. Dong Z; Tao Q; Yan B; Sun G PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]